Dahiroc, Rachel L.

HRN: 04-03-01  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/12/2025
CEFTRIAXONE 1G (VIAL)
05/12/2025
05/19/2025
IV
2g
OD
UTI
Waiting Final Action 
05/14/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
05/14/2025
05/20/2025
IV
2.25g
Q12
UTI, Pneumonia
Waiting Final Action 
05/14/2025
AZITHROMYCIN 500MG TABLET (TAB)
05/14/2025
05/18/2025
PO
500mg
OD
Pneumonia
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: